ON24 CEO Exercises Options and Sells 37,982 Shares
Rhea-AI Filing Summary
ON24 Inc. President and Chief Executive Sharan Sharat exercised stock options for 62,206 shares of common stock at an exercise price of $0.89 per share and sold 37,982 shares of common stock at a weighted average price of $4.8731, with individual trades between $4.78 and $4.94. The options involved were fully vested and exercisable, and the transactions were carried out under a Rule 10b5-1 trading plan adopted on December 12, 2024. Following these transactions, Sharat directly holds 3,599,563 shares of ON24 common stock.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider exercised 62,206 options at $0.89 and sold 37,982 shares at a $4.8731 weighted average under a 10b5-1 plan.
The filing documents a two-part transaction: an option exercise converting 62,206 derivative securities into common stock at a $0.89 exercise/conversion price, and a contemporaneous sale of 37,982 shares that reported a weighted average sale price of $4.8731. The sale was effected under a Rule 10b5-1 plan adopted on December 12, 2024, and the filer states the sales occurred across multiple transactions priced between $4.78 and $4.94. The options are noted as fully vested and exercisable. Impact is informational for share count and insider liquidity; no additional corporate performance data is included in the filing.
TL;DR: Pre-arranged 10b5-1 plan and attorney-in-fact signature; transaction adjusts insider holdings modestly.
The Form 4 indicates the transactions were conducted pursuant to a Rule 10b5-1 trading plan and the filing bears an attorney-in-fact signature on behalf of the reporting person. The document shows an acquisition via exercise of 62,206 option-derived shares and a sale of 37,982 shares, with post-transaction beneficial ownership figures reported as 3,637,545 and 3,599,563 on the two lines. The options related to the exercise are explicitly stated to be fully vested and exercisable. From a governance perspective, the use of a 10b5-1 plan and an attorney-in-fact are material procedural details; the filing does not disclose additional governance changes or material corporate actions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 62,206 | $0.00 | $0.00 |
| Exercise | Common Stock | 62,206 | $0.89 | $55K |
| Sale | Common Stock | 37,982 | $4.8731 | $185K |
Footnotes (3)
- F1. The transaction reported in this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on December 12, 2024.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.78 to $4.94 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3. The options are fully vested and exercisable.
Key Figures
Key Terms
Rule 10B5-1 trading plan financial
weighted average price financial
fully vested and exercisable financial
FAQ
What did ONTF CEO Sharan Sharat report in this Form 4?
What options did ONTF CEO Sharan Sharat exercise in this filing?
Were Sharan Sharat’s ONTF trades made under a 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.